Hyperpolarized C-13 pyuvate metabolic MR imaging of solid tumor liver metastases as a biomarker of PI3K/mTOR pathway activity. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I.
Real-world outcomes among patients with metastatic castration-resistant prostate cancer (mCRPC) receiving guideline-recommended therapies after treatment with 177Lu-PSMA-617: A real-world prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results